D-Glutamine

Generic Name
D-Glutamine
Brand Names
Endari
Drug Type
Small Molecule
Chemical Formula
C5H10N2O3
CAS Number
5959-95-5
Unique Ingredient Identifier
63HB36CA2Y
Background

A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells.

Indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance.

Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older .

Associated Conditions
Osteoporosis, Acute Complications of Sickle Cell Disease
Associated Therapies
-

Complementary Naturopathic Medicine for Periodontitis

Phase 2
Completed
Conditions
First Posted Date
2001-02-05
Last Posted Date
2006-08-18
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Registration Number
NCT00010634
Locations
🇺🇸

The Oregon Health Sciences University (OHSU), Portland, Oregon, United States

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

First Posted Date
2000-06-05
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
96
Registration Number
NCT00005889
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

First Posted Date
2000-06-02
Last Posted Date
2015-06-08
Lead Sponsor
NICHD Neonatal Research Network
Target Recruit Count
1433
Registration Number
NCT00005775
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States

🇺🇸

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

and more 12 locations
© Copyright 2024. All Rights Reserved by MedPath